WORK Medical Technology Group LTD Partners with Hong Kong Web3.0 Standardization Association to Collaborate on Blockchain and RWA Innovations
WORK Medical Technology Group (NASDAQ:WOK) has announced a strategic partnership with the Hong Kong Web3.0 Standardization Association Limited to innovate in blockchain and Real-world Asset (RWA) solutions. The collaboration focuses on three key areas: asset tokenization, joint investment vehicles, and RWA technology development.
As part of the agreement, WORK Medical has been appointed as a Vice President Unit of the Association. The partnership aims to leverage WORK Medical's status as a Nasdaq-listed medical device manufacturer and the Association's Web3.0 expertise to develop compliant blockchain solutions for asset tokenization and cross-chain transactions.
WORK Medical Technology Group (NASDAQ:WOK) ha annunciato una partnership strategica con la Hong Kong Web3.0 Standardization Association Limited per innovare nelle soluzioni blockchain e di Real-world Asset (RWA). La collaborazione si concentra su tre ambiti chiave: tokenizzazione degli asset, veicoli di investimento congiunti e sviluppo della tecnologia RWA.
Nell'ambito dell'accordo, WORK Medical è stato nominato Vice President Unit dell'Associazione. L'obiettivo della partnership è sfruttare lo status di WORK Medical come produttore di dispositivi medici quotato al Nasdaq e l'expertise della Web3.0 dell'Associazione per sviluppare soluzioni blockchain conformi per la tokenizzazione degli asset e le transazioni cross-chain.
WORK Medical Technology Group (NASDAQ:WOK) ha anunciado una asociación estratégica con la Hong Kong Web3.0 Standardization Association Limited para innovar en soluciones de blockchain y de Activos del mundo real (RWA). La colaboración se centra en tres áreas clave: tokenización de activos, vehículos de inversión conjuntos y desarrollo de tecnología RWA.
Como parte del acuerdo, WORK Medical ha sido designado como Unidad Vicepresidente de la Asociación. La asociación busca aprovechar el estatus de WORK Medical como fabricante de dispositivos médicos cotizado en Nasdaq y la experiencia de Web3.0 de la Asociación para desarrollar soluciones blockchain compatibles para la tokenización de activos y transacciones entre cadenas.
WORK Medical Technology Group (NASDAQ:WOK)가 홍콩 Web3.0 표준화 협회 유한회사와 전략적 파트너십을 발표하며 블록체인 및 Real-world Asset(RWA) 솔루션의 혁신을 추진합니다. 협력은 세 가지 핵심 영역에 집중합니다: 자산 토큰화, 공동 투자 차량, 그리고 RWA 기술 개발.
협약의 일환으로 WORK Medical은 협회의 부사장단으로 임명되었습니다. 이 파트너십은 나스닥에 상장된 의료기기 제조업체로서의 WORK Medical의 지위와 협회의 Web3.0 전문성을 활용하여 자산 토큰화 및 교차 체인 거래에 적합한 규정을 준수하는 블록체인 솔루션을 개발하는 것을 목표로 합니다.
WORK Medical Technology Group (NASDAQ:WOK) a annoncé un partenariat stratégique avec la Hong Kong Web3.0 Standardization Association Limited pour innover dans les solutions blockchain et d’actifs du monde réel (RWA). La collaboration se concentre sur trois domaines clés : la tokenisation des actifs, des véhicules d’investissement conjoints et le développement de la technologie RWA.
Dans le cadre de cet accord, WORK Medical a été nommé Unit de Vice-président de l’Association. Le partenariat vise à tirer parti du statut de WORK Medical en tant que fabricant de dispositifs médicaux cotés au Nasdaq et de l’expertise Web3.0 de l’Association pour développer des solutions blockchain conformes à la tokenisation des actifs et aux transactions cross-chain.
WORK Medical Technology Group (NASDAQ:WOK) hat eine strategische Partnerschaft mit der Hong Kong Web3.0 Standardization Association Limited angekündigt, um Innovationen im Bereich Blockchain und Real-world Asset (RWA)-Lösungen zu entwickeln. Die Zusammenarbeit konzentriert sich auf drei Kernbereiche: Asset-Tokenisierung, gemeinsame Investmentvehikel und Entwicklung der RWA-Technologie.
Im Rahmen der Vereinbarung wurde WORK Medical als Vizepräsidenten-Einheit der Vereinigung ernannt. Ziel der Partnerschaft ist es, den Status von WORK Medical als an der Nasdaq gelisteten Medizintechnikhersteller und die Web3.0-Expertise der Vereinigung zu nutzen, um konforme Blockchain-Lösungen für die Tokenisierung von Vermögenswerten und Cross-Chain-Transaktionen zu entwickeln.
WORK Medical Technology Group (NASDAQ:WOK) أعلنت عن شراكة استراتيجية مع جمعية هونغ كونغ لتوحيد معايير Web3.0 المحدودة بهدف الابتكار في حلول البلوك تشين والأصول الواقعية (RWA). تتركز الشراكة على ثلاثة مجالات رئيسية: ترميز الأصول، وآليات الاستثمار المشتركة، وتطوير تكنولوجيا RWA.
كجزء من الاتفاق، تم تعيين WORK Medical كـ وحدة نائب رئيس للجمعية. تهدف الشراكة إلى الاستفادة من وضع WORK Medical كمصنّع أجهزة طبية مُدرج في ناسداك وخبرة الجمعية في Web3.0 لتطوير حلول بلوكتشين متوافقة لترميز الأصول ومعاملات عبر السلاسل.
WORK Medical Technology Group (NASDAQ:WOK) 宣布与 香港Web3.0标准化协会有限公司 建立战略伙伴关系,在区块链及现实世界资产(RWA)解决方案方面进行创新。该合作聚焦三个关键领域:资产代币化、联合投资工具,以及RWA技术开发。
根据协议,WORK Medical已被任命为该协会的副主席单位。本次伙伴关系旨在利用WORK Medical作为纳斯达克上市医疗器械制造商的身份,以及协会在Web3.0方面的专业知识,开发符合规范的区块链解决方案,用于资产代币化和跨链交易。
- Strategic partnership with Hong Kong Web3.0 Standardization Association enhances blockchain capabilities
- Appointment as Vice President Unit of the Association strengthens industry position
- Access to new RWA registration platform for asset tokenization
- None.
Insights
WORK Medical's blockchain partnership signals strategic diversification but lacks concrete financial impact details or implementation timeline.
WORK Medical, primarily a medical device supplier in China, has entered a strategic cooperation agreement with the Hong Kong Web3.0 Standardization Association to develop blockchain solutions for asset tokenization and Real-world Asset (RWA) innovations.
This partnership marks a significant strategic pivot for WORK Medical, potentially diversifying beyond its core medical device business into blockchain technology. The company will focus on three main areas: tokenizing its high-quality assets, creating joint investment vehicles, and developing RWA technology on the Association's registration platform launched in August 2025.
What's notable is WORK Medical's appointment as a Vice President Unit of the Association, suggesting a leadership role in this collaboration rather than merely participating. This positions the company to potentially influence emerging Web3.0 standards in Hong Kong's developing digital ecosystem.
However, the announcement lacks specific financial commitments, implementation timelines, or revenue projections. There's no clear indication of how quickly this partnership will translate into tangible business outcomes or how it aligns with the company's existing medical device operations.
The strategic value lies in WORK Medical leveraging its Nasdaq-listed status and capital resources to potentially create new asset classes through tokenization, though the regulatory framework and market demand for such offerings remain uncertain. This move represents a speculative venture into an emerging technology space rather than an immediate business catalyst.
Hangzhou, China, Sept. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into a strategic cooperation agreement (the “Agreement”) with Hong Kong Web3.0 Standardization Association Limited (the “Association”), an organization dedicated to standardization research in the Web3.0 sector, with a mission to promote the high-quality development of the global Web3.0 industry through standardization efforts. The partnership is expected to demonstrate resource sharing and complementary strengths, with the goal of pioneering innovation in the Real-world Asset (the “RWA”) sector. In recognition of this collaboration, WORK Medical has also been appointed as a Vice President Unit of the Association.
Caption: Work Medical and Hong Kong Web3.0 Standardization Association Limited sign a strategic cooperation agreement.
Pursuant to the Agreement, WORK Medical and the Association agree to collaborate on comprehensive, systematic and compliant blockchain solutions in areas such as asset tokenization, equity investment, and RWA technology development. Leveraging their respective technological capabilities and resource advantages, the parties aim to jointly explore new technologies and business models to drive mutual growth and strengthen industry influence, with a focus on:
- Asset Tokenization: Combining WORK Medical’s capital resources as a Nasdaq-listed company and its expertise in medical device manufacturing, with the Association’s resources and RWA platform, to advance the tokenization of the high-quality assets owned or invested in by WORK Medical.
- Joint Investment/Financial Vehicles: Integrating industrial and financial resources through co-investments or participation in funds and other investment/financial vehicles to accelerate the RWA market expansion and achieve shared strategic objectives.
- RWA Technology Development: Leveraging the Association’s newly launched RWA registration platform to collaborate on blockchain-based title verification of industry applications, asset issuance, and cross-chain transactions, while ensuring regulatory compliance of data assets and the secure issuance of assets throughout the collaboration.
The Hong Kong Web3.0 Standardization Association Limited is a cross-industry, non-profit organization committed to supporting the growth of Hong Kong’s Web3.0 ecosystem. Its initiatives include promoting technological advancement and industry upgrading, establishing standards, conducting professional research, and providing insights for future development. The Association also supports government policy implementation, enhances public awareness of Web3.0, and trains professionals, endeavoring to contribute to Hong Kong’s vision of becoming a world-leading Web3.0 smart city and a secure, sustainable digital financial hub. In August 2025, it furthered this mission by launching an RWA registration platform.
Mr. Wu Shuang, chief executive officer and chairman of the board of directors of WORK Medical, commented: “We are excited to establish a partnership with the Hong Kong Web3.0 Standardization Association, a milestone in our pursuit of innovation in the RWA domain. We endeavor to participate with the Association in the process of becoming a standard setter in this space while leveraging our strengths to drive innovation and accelerate the commercial adoption of RWA solutions.
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company’s website: https://www.workmedtech.com/corporate.
Forward-Looking Statements
This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Any forward-looking statements in this press release are based on the Company’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company’s annual report on Form 20-F and other documents filed by the Company with the U.S. Securities and Exchange Commission. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
For more information, please contact:
WORK Medical Technology Group LTD
Investor Relations Department
Email: ir@workmedtech.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
